OTC · Medical - Care Facilities

Fresenius Medical Care AG (FMCQF) Stock

$44.59 +0.00% OTC: FMCQF Healthcare

Fresenius Medical Care AG engages in the provision of products and services for individuals with renal diseases. It operates through the Care Enablement and Care Delivery segments.

Valuation

MetricValue
Price$44.59
Market Cap$11.98B
P/E Ratio12.84
P/B Ratio0.88
P/S Ratio0.58
EPS (TTM)$3.47
52-Week High$56.24
52-Week Low$42.00
Dividend Yield3.88%

Financials & Margins

MetricValue
ROE7.16%
ROA3.00%
ROCE7.96%
Gross Margin25.96%
Operating Margin10.17%
Net Margin4.88%
Debt/Equity0.83
Current Ratio1.20

Annual Financials (USD)

Metric20212022202320242025
Revenue$17.6B$19.4B$19.5B$19.3B$19.6B
Operating Profit$1.9B$1.5B$1.4B$1.4B$1.8B
Net Profit$969.0M$673.0M$499.0M$538.0M$978.0M
EPS$3.31$2.30$1.70$1.83$3.35
Op Margin10.8%7.8%7.0%7.2%9.4%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$34.4B$35.8B$33.9B$33.6B$31.0B
Total Liabilities$20.4B$20.3B$19.1B$17.8B$16.7B
Cash$1.5B$1.3B$1.4B$1.2B$1.6B
Borrowings$13.3B$13.2B$12.1B$11.0B$10.8B

Latest News

European Equities Traded in US as ADRs Decline MT Newswires · Jul 13, 2026 Reasons to Retain Fresenius Medical Stock in Your Portfolio for Now Zacks · Jul 8, 2026 DaVita Stock Benefits From Strengthening Kidney Care Delivery Zacks · Jun 30, 2026 Fresenius Medical Care (XTRA:FME) Faces EU Setback After TAVNEOS Revocation Recommendation Simply Wall St. · Jun 28, 2026 CHMP recommends revoking marketing authorisation for TAVNEOS® (avacopan) in the European Union PR Newswire · Jun 26, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$2.5B$2.2B$2.6B$2.4B$2.7B
Investing Cash Flow$-2.9B$-2.1B$-1.2B$-784.0M$-1.6B
Financing Cash Flow$-280.0M$-219.0M$-340.0M$-315.0M$-1.8B
Net Cash Flow$400.0M$-208.0M$153.0M$-242.0M$559.0M
Free Cash Flow$806.0M$756.0M$1.9B$1.7B$1.8B

Valuation & Return Ratios

MetricValue
PEG Ratio0.23
EV / EBITDA6.08
FCF Yield15.78%
Quick Ratio0.86
Interest Coverage5.15
Return 1Y-16.83%
Return 3Y-0.27%
Return 5Y-38.38%

Ownership

Insiders Held31.23%
Institutions Held48.97%
Institutions Float Held71.20%
Institutional HolderSharesReport Date
Pacer Advisors, Inc.275,0002026-03-31
Paradigm Asset Management Company, LLC6972026-03-31
Generali Investments Cee, Investicni Spolecnost, A.s.9,1002026-06-30

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $313.33 +0.29% 37.72 $4.60T 0.34%
MSFTMicrosoft Corporation $499.99 +0.03% 22.95 $3.71T 0.94%
GOOGLAlphabet Inc. $354.30 -0.96% 27.68 $4.29T 0.23%
AMZNAmazon.com, Inc. $274.48 +0.82% 28.76 $2.95T 0.00%
METAMeta Platforms, Inc. $592.10 +0.37% 21.47 $1.51T 0.35%

About Fresenius Medical Care AG

Fresenius Medical Care AG engages in the provision of products and services for individuals with renal diseases. It operates through the Care Enablement and Care Delivery segments. The Care Enablement segment is involved in the healthcare products business including research and development, manufacturing, supply chain, and commercial operations as well as supporting functions, such as regulatory and quality management. The Care Delivery segment focuses on the health care services for the treatment of CKD, ESRD, and other extracorporeal therapies, including value and risk-based care programs. The company was founded on August 5, 1996 and is headquartered in Bad Homburg, Germany.

Fresenius Medical Care AG is headquartered in DE.

Fresenius Medical Care AG (FMCQF) stock trades at $44.59 with a market capitalization of $11.98B. The stock is valued at a price-to-earnings (P/E) ratio of 12.84, price-to-book of 0.88, price-to-sales of 0.58. Over the past 52 weeks the stock has ranged between $42.00 and $56.24, and currently trades 20.7% below its 52-week high. It pays a dividend yielding 3.88%.

On profitability, Fresenius Medical Care AG generates a return on equity (ROE) of 7.16%, return on capital employed of 7.96%, an operating margin of 10.17%, a net profit margin of 4.88%.

Official website: www.freseniusmedicalcare.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides